Drug Type Small molecule drug |
Synonyms HIF-2α激动剂(山东大学) |
Target |
Mechanism HIF-2α agonists(Endothelial PAS domain-containing protein 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anemia | Preclinical | CN | 27 Feb 2023 |